Health Care & Life Sciences » Biotechnology | Marina Biotech Inc.

Marina Biotech Inc.

Marina Biotech Inc.
Stock Exchange Other OTC
Market Cap
$4.92 B
Shares Outstanding
329.01 M
Public Float
190.26 M


200 Technology Square
Cambridge Massachusetts 02139
United States
Employees -
Updated 07/08/2019
Marina Biotech, Inc. is a biotechnology company, which is engages in the discovery, development, and commercialization of drug therapeutics for hypertension. It offers Perstalia, which contains perindopril arginine, an angiotensin converting enzyme inhibitor, and amlodipine, a dihydropyridine calcium channel blocker, and is indicated for the treatment of hypertension. The company was founded on September 23, 1983 and is headquartered in City of Industry, CA.


View All

Uli Alf Hacksell
Robert C. Moscato
Chief Executive Officer & Director